MARKET

AZTR

AZTR

Azitra Inc
AMEX
0.1320
+0.0035
+2.72%
After Hours: 0.1340 +0.002 +1.52% 19:44 10/02 EDT
OPEN
0.1337
PREV CLOSE
0.1285
HIGH
0.1383
LOW
0.1297
VOLUME
825.84K
TURNOVER
--
52 WEEK HIGH
1.090
52 WEEK LOW
0.1000
MARKET CAP
8.00M
P/E (TTM)
-0.1014
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 3d ago
Azitra Advances ATR04-484 Trial to Second Cohort
TipRanks · 3d ago
Azitra completes Cohort 1 in Phase 1/2 clinical trial evaluating ATR04-484
TipRanks · 3d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 5d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 5d ago
Azitra Launches At-the-Market Equity Offering Program
TipRanks · 6d ago
Azitra Enters Sales Agreement With A.G.P. For Common Stock Offering; May Offer Common Stock Up To $3.50M Through A.G.P.
Benzinga · 6d ago
Weekly Report: what happened at AZTR last week (0921-0925)?
Weekly Report · 6d ago
More
About AZTR
Azitra, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing advanced therapies for precision dermatology using engineered proteins and topical live bio therapeutic products. It has built a proprietary platform that includes a microbial library comprised of approximately 1,500 unique bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its lead product, ATR-12, is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its advanced product, ATR-04, is a genetically modified strain of S. epidermidis for treating papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, chronic, xerotic (abnormally dry), and scaly skin disease.

Webull offers Azitra Inc stock information, including AMEX: AZTR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZTR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZTR stock methods without spending real money on the virtual paper trading platform.